Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer. 1994

M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
Department of Gastroenterology, Meitetsu Hospital, Nagoya.

Thirty-four patients with advanced gastric cancer were treated with combination chemotherapy employing Tegafur-Uracil (UFT), etoposide, Adriamycin, and Cisplatinum (CDDP) (UFT-EAP therapy). An objective partial response was obtained in 16 patients (47%) and the median duration of remission was 12.2 months. The 50% survival time for all 34 patients was 10 months. Patients with moderately or well differentiated adenocarcinoma responded well (13/19, 68%), while those with undifferentiated adenocarcinoma showed a poor response (3/15, 20%). Six responding patients were noted to have no evidence of viable cancer at the primary site by endoscopic biopsy, and underwent gastrectomies. The resected specimens showed complete disappearances of the primary tumors in four patients. The median survival time for the patients receiving gastrectomies was 24 months. The regimen was very well tolerated, apart from moderate bone marrow suppression. Our results suggest that patients with advanced gastric cancer can be effectively treated with UFT-EAP chemotherapy.

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration

Related Publications

M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
September 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
June 1990, Onkologie,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
November 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
October 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
July 1991, Hinyokika kiyo. Acta urologica Japonica,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
April 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
March 2001, International journal of urology : official journal of the Japanese Urological Association,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
September 1987, Gan no rinsho. Japan journal of cancer clinics,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
April 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
M Hayakawa, and K Morise, and K Chin, and M Sugihara, and Y Morooka, and H Maeda, and T Hattori, and H Saito
April 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!